223 related articles for article (PubMed ID: 32047231)
1. Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation.
Williams DS; Mouradov D; Newman MR; Amini E; Nickless DK; Fang CG; Palmieri M; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Skinner I; Jones I; Gibbs P; Sieber OM
Mod Pathol; 2020 Jul; 33(7):1420-1432. PubMed ID: 32047231
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features, Molecular Alterations and Prognosis of Colorectal Adenocarcinoma With Mucinous Component in Chinese Patients.
Jia X; Li B; Wang H; Yan Z
Appl Immunohistochem Mol Morphol; 2021 Nov-Dec 01; 29(10):765-772. PubMed ID: 34081634
[TBL] [Abstract][Full Text] [Related]
4. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
5. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features and prognostic value of KRAS, NRAS and BRAF mutations and DNA mismatch repair status: A single-center retrospective study of 1,834 Chinese patients with Stage I-IV colorectal cancer.
Guo TA; Wu YC; Tan C; Jin YT; Sheng WQ; Cai SJ; Liu FQ; Xu Y
Int J Cancer; 2019 Sep; 145(6):1625-1634. PubMed ID: 31162857
[TBL] [Abstract][Full Text] [Related]
7. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.
Ye JX; Liu Y; Qin Y; Zhong HH; Yi WN; Shi XY
World J Gastroenterol; 2015 Feb; 21(5):1595-605. PubMed ID: 25663779
[TBL] [Abstract][Full Text] [Related]
8. Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component.
Li X; Sun K; Liao X; Gao H; Zhu H; Xu R
BMC Cancer; 2020 May; 20(1):400. PubMed ID: 32384877
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis.
Gil-Raga M; Jantus-Lewintre E; Gallach S; Giner-Bosch V; Frangi-Caregnato A; Safont-Aguilera MJ; Garde-Noguera J; Zorraquino-Pina E; García-Martínez M; Camps-Herrero C
Clin Transl Oncol; 2018 Nov; 20(11):1422-1429. PubMed ID: 29802524
[TBL] [Abstract][Full Text] [Related]
10. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.
Venderbosch S; Nagtegaal ID; Maughan TS; Smith CG; Cheadle JP; Fisher D; Kaplan R; Quirke P; Seymour MT; Richman SD; Meijer GA; Ylstra B; Heideman DA; de Haan AF; Punt CJ; Koopman M
Clin Cancer Res; 2014 Oct; 20(20):5322-30. PubMed ID: 25139339
[TBL] [Abstract][Full Text] [Related]
11. Mucinous differentiation in colorectal cancer--indicator of poor prognosis?
Langner C; Harbaum L; Pollheimer MJ; Kornprat P; Lindtner RA; Schlemmer A; Vieth M; Rehak P
Histopathology; 2012 Jun; 60(7):1060-72. PubMed ID: 22348346
[TBL] [Abstract][Full Text] [Related]
12. Synaptophysin expression in
Fassan M; Milione M; Maddalena G; Cremolini C; Schirripa M; Pietrantonio F; Pella N; Dell'Aquila E; Sperti E; Zichi C; Bergamo F; Volante M; Boccaccino A; Morano F; Cortiula F; De Maglio G; Rimassa L; Smiroldo V; Calvetti L; Aprile G; Salvatore L; Santini D; Salmaso R; Centonze G; Biason P; Borga C; Lonardi S; Zagonel V; Dei Tos AP; Di Maio M; Loupakis F
Eur J Cancer; 2021 Mar; 146():145-154. PubMed ID: 33607478
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
14. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
[TBL] [Abstract][Full Text] [Related]
15. Correlation of clinical, pathologic, and genetic parameters with intratumoral immune milieu in mucinous adenocarcinoma of the colon.
Neyaz A; Pankaj A; Crabbe A; Rickelt S; Leijssen L; Dinaux A; Taylor M; Shroff SG; Crotty R; Zhang ML; Yilmaz OH; Yılmaz O; Patil DT; Parikh AR; Ting DT; Berger D; Deshpande V
Mod Pathol; 2022 Nov; 35(11):1723-1731. PubMed ID: 35590108
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer.
Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC
Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219
[TBL] [Abstract][Full Text] [Related]
17. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.
Li WQ; Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Iacopetta B
Mol Cancer; 2006 Jan; 5():2. PubMed ID: 16403224
[TBL] [Abstract][Full Text] [Related]
18. ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer.
Roseweir AK; Halcrow ES; Chichilo S; Powell AG; McMillan DC; Horgan PG; Edwards J
Br J Cancer; 2018 Aug; 119(3):323-329. PubMed ID: 29988110
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
Inamura K; Yamauchi M; Nishihara R; Kim SA; Mima K; Sukawa Y; Li T; Yasunari M; Zhang X; Wu K; Meyerhardt JA; Fuchs CS; Harris CC; Qian ZR; Ogino S
Ann Surg Oncol; 2015 Apr; 22(4):1226-1235. PubMed ID: 25326395
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the BRAF gene in colorectal mucinous carcinoma in association with histological configuration.
Yoshitake N; Fujii S; Mukawa K; Tominaga K; Fukui H; Ichikawa K; Tomita S; Ono Y; Imai Y; Terano A; Hiraishi H; Fujimori T
Oncol Rep; 2007 Jan; 17(1):9-15. PubMed ID: 17143472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
